BREMER TRUST NATIONAL ASSOCIATION - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 848 filers reported holding GLAXOSMITHKLINE PLC in Q1 2019. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
BREMER TRUST NATIONAL ASSOCIATION ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q4 2018$276,000
-24.0%
7,242
-19.8%
0.06%
-34.1%
Q3 2018$363,000
+3.7%
9,031
+4.0%
0.09%
-6.2%
Q2 2018$350,000
-6.4%
8,682
-9.4%
0.10%
-10.2%
Q1 2018$374,000
+27.2%
9,582
+15.9%
0.11%
+36.7%
Q4 2017$294,000
-8.7%
8,264
+4.5%
0.08%
-12.2%
Q3 2017$322,000
-5.3%
7,909
+0.4%
0.09%
-6.2%
Q2 2017$340,000
-3.7%
7,878
-5.8%
0.10%0.0%
Q1 2017$353,000
-1.7%
8,364
-10.1%
0.10%
-2.0%
Q4 2016$359,000
-27.5%
9,308
-19.0%
0.10%
-27.4%
Q3 2016$495,000
+4.7%
11,486
+5.2%
0.14%
+3.1%
Q2 2016$473,000
+18.2%
10,923
+10.5%
0.13%
+13.9%
Q1 2016$400,000
+10.2%
9,882
+9.9%
0.12%
+5.5%
Q4 2015$363,000
+38.5%
8,993
+31.7%
0.11%
+26.7%
Q3 2015$262,000
-39.9%
6,830
-34.8%
0.09%
-33.8%
Q2 2015$436,000
-10.7%
10,480
-1.0%
0.13%
-16.1%
Q1 2015$488,000
-7.0%
10,589
-13.9%
0.16%
-7.7%
Q4 2014$525,000
-2.8%
12,298
+4.7%
0.17%
-8.2%
Q3 2014$540,000
-16.0%
11,742
-2.4%
0.18%
-19.0%
Q2 2014$643,000
+4.2%
12,025
+4.0%
0.23%
-0.4%
Q1 2014$617,000
-2.1%
11,564
-2.0%
0.23%
-4.6%
Q4 2013$630,000
+6.1%
11,806
-0.4%
0.24%
-5.6%
Q3 2013$594,000
-5.6%
11,850
-5.8%
0.25%
-10.6%
Q2 2013$629,00012,5790.28%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q1 2019
NameSharesValueWeighting ↓
OSTERWEIS CAPITAL MANAGEMENT INC 1,948,915$79,029,0004.59%
Chubb Ltd 400,000$16,220,0004.42%
Pegasus Partners Ltd. 172,275$6,986,0003.79%
Keystone Financial Planning, Inc. 117,762$4,775,0003.42%
P.R. Herzig & Co. Inc. 36,950$1,498,0003.28%
Sterneck Capital Management, LLC 112,535$4,563,0003.21%
Hamlin Capital Management, LLC 1,454,031$58,961,0002.98%
Healthcare Value Capital, LLC 50,000$2,028,0002.98%
Jolley Asset Management, LLC 80,639$3,270,0002.98%
JFB Holdings Corp 2,415,570$97,951,0002.91%
View complete list of GLAXOSMITHKLINE PLC shareholders